Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

85.78
-0.7000-0.81%
Pre-market: 85.780.00000.00%04:00 EDT
Volume:3.51M
Turnover:302.08M
Market Cap:49.46B
PE:49.90
High:87.30
Open:86.65
Low:85.49
Close:86.48
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:1.03
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.66
PE(LYR):46.80

Loading ...

Aquarius Crosses 10% Stake in Carvolix, Holds 11.65% of Shares

Reuters
·
Aug 17

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 15

Edwards Lifesciences CVP TAVR Daniel J. Lippis Melepas 619 Saham Senilai $ 56.966,57

Reuters
·
Aug 12

EW Scripps is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Aug 11

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

AdAlta’s EW-001 CAR-T Shows Promising Survival and Response in Advanced Mesothelioma

TIPRANKS
·
Aug 10

Carvolix Flags Aquarius Stake at 11.65% of Capital, 9.07% of Voting Rights

Reuters
·
Aug 07

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 04

Movement Alert|Edwards Lifesciences Rises 3.1% in Regular Trading, Multiple Wall Street Firms Upgrade Ratings After Strong Q2 Beat

Market Focus
·
Aug 04

ISRG, EW, RBLX, CAT, CAKE: Trending Analyst Calls

TIPRANKS
·
Aug 01

Edwards Lifesciences Executive Makes Notable Move With Fresh Insider Trade

TIPRANKS
·
Jul 31

Edwards Lifesciences CVP JAPAC Wayne Markowitz Sells 146 Shares for $12,587.2

Reuters
·
Jul 31

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 30

How Stronger 2026 Sales Outlook And Q2 Results At Edwards Lifesciences (EW) Have Changed Its Investment Story

Simply Wall St.
·
Jul 29

UBS Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $110 From $90

MT Newswires Live
·
Jul 28

Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Insmed (INSM) and Edwards Lifesciences (EW)

TIPRANKS
·
Jul 28

Top Executive Cashes In on Major Edwards Lifesciences Stock Move

TIPRANKS
·
Jul 28

Edwards Lifesciences CEO Bernard J. Zovighian Disposes of 2,920 Shares for $245,082.66

Reuters
·
Jul 28

Rothschild & Co Redburn Adjusts Edwards Lifesciences Price Target to $102 From $99, Maintains Buy Rating

MT Newswires Live
·
Jul 27

Edwards Lifesciences Lifts Outlook On TAVR And TMTT

TIPRANKS
·
Jul 25